(Total Views: 320)
Posted On: 12/02/2019 4:00:30 PM
Post# of 11803
Re: weaver_525 #8317
Wow, another diabetes product for dogs and cats. To bad the first product that was touted to do $12 to $20 million yearly revenue failed to live up to the hype. Wasn't the first product in PetSmart?
Sad to say but this will be the subject matter just another failed hyped-up press release in the future.
With all the quality articles and research that you find on the diabetic epidemic, I can't help but wonder why all of the Company's products have failed to deliver meaningful sales. The products seemed to be priced to be very affordable. It just goes to show how powerful Big Pharma and the distribution networks are. That being stated, most distribution channels and retailers would be dubious of slotting shelve space to a Company that always appears to be on the brink of bankruptcy.
Sad to say but this will be the subject matter just another failed hyped-up press release in the future.
With all the quality articles and research that you find on the diabetic epidemic, I can't help but wonder why all of the Company's products have failed to deliver meaningful sales. The products seemed to be priced to be very affordable. It just goes to show how powerful Big Pharma and the distribution networks are. That being stated, most distribution channels and retailers would be dubious of slotting shelve space to a Company that always appears to be on the brink of bankruptcy.
(1)
(0)
